UPS Opens New Healthcare Facility In Colombia

CO 06/05/17


Strategic investments in healthcare logistics to serve the growing pharmaceutical, biopharma and medical device industry in Latin America

UPS (NYSE: UPS) today announced the opening of its new healthcare-dedicated facility in Colombia. The 76,000-square-foot center represents UPS’s latest investment in healthcare logistics aimed at helping pharmaceutical, biopharma and medical device companies create seamless, global supply chains as they expand into, transport within, and export from Latin America.

The multi-client facility is equipped with state-of-the-art technology for storing temperature-sensitive healthcare products. The building offers best-in-class distribution services, warehouse management, and late-stage customization solutions such as labeling, product kitting and configuration, and repackaging.

“This latest announcement represents part of UPS’s long-term strategy to strengthen its integrated healthcare network to help manufacturers lower costs, streamline inventory and meet increasing demands across Latin America and the world,” said Francisco Ricaurte, UPS Colombia country manager. “When it comes to high-value, sensitive products, this investment demonstrates our ongoing commitment to the healthcare and life science industries, and to our mantra, It’s a patient, not a package.”

The Colombia facility features the latest in sorting, processing and data capture technology available through UPS’s validated warehouse management system, providing customers full inventory visibility, standardized processing and reporting. Furthermore, customers will have access to UPS’s global transportation technology network for complete control of their supply chains.

The facility is Current Good Manufacturing Practice (cGMP) compliant, and follows international and local regulations required by the Colombian Drug Regulatory Authority (Instituto Nacional de Vigilancia del Medicamento - INVIMA) and the Colombian Ministry of Health. The building is located near El Dorado International Airport in San Diego Industrial Park in the Funza, Cundinamarca area of Colombia.

“Latin America is a vital region for the global healthcare industry,” said Romaine Seguin, UPS Americas region president. “This facility offers greater access to UPS’s first-class logistics solutions for pharmaceutical products and medical devices, providing healthcare customers in the region with the confidence and support they need to achieve their business goals.” 

UPS has been serving customers in the healthcare industry in Colombia for 11 years. This is the second healthcare-dedicated facility in the country and the ninth in the region. In Latin America, UPS distribution centers are located in Argentina, Brazil, Chile, México and Puerto Rico.

About UPS

UPS (NYSE: UPS) is a global leader in logistics, offering a broad range of solutions including transporting packages and freight; facilitating international trade, and deploying advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. The company can be found on the web at and its corporate blog can be found at To get UPS news direct, visit or follow @UPS_News.

About UPS Healthcare

UPS provides best-in-class, global supply chain solutions and compliance expertise to pharmaceutical, biopharma and medical device companies. UPS has 60+ healthcare-dedicated facilities and 7 million square feet of cGMP- or cGDP-compliant healthcare distribution space. UPS also maintains the world’s largest network of field stocking locations with 950 sites. For parcels requiring strict temperature environments, from CRT to cryogenic, and those requiring around-the-clock monitoring, UPS has solutions such as UPS Temperature True™ and UPS Proactive Response™. UPS is committed to expanding its healthcare capabilities including recent acquisitions of Marken, CEMELOG and Poltraf, to meet the complex and evolving supply chain needs of the healthcare and life science sectors. Visit


For more information about this press release, contact: